Jpmorgan Chase & CO Tenaya Therapeutics, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 24,822 shares of TNYA stock, worth $59,076. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,822
Previous 24,161
2.74%
Holding current value
$59,076
Previous $74,000
36.49%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$22.4 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$16.6 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$16 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$9.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$7.65 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $98.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...